Literature DB >> 8717394

Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys.

G M Ignatyev1, A P Agafonov, M A Streltsova, E A Kashentseva.   

Abstract

In the present work the kinetics of some indices of immunity (tumor necrosis factor (TNF), interferon (IFN), natural killer cells (NK), lymphocyte proliferation activity, virus-specific antibodies, CD4/CD8 ratio) in response to Marburg virus infection in Macaca mulatta were studied. The different kinetics of immunological parameters for animals which survived Marburg virus infection and for animals which died after infection are shown. A comparison of the indices of IFN, TNF and spontaneous lymphocyte proliferation activity in Macaca mulatta infected with Marburg virus at different stages of life shows the relationship between the increase of these indices and the decrease in the animals' lifespan. Marburg virus immunosuppressive properties were corroborated by studying lymphocyte proliferation activity in response to antigenic stimulation in vitro and the CD4/CD8 index during experimental Marburg virus infection in Macaca mulatta. We conclude that the disease outcome depends on the dynamics of certain immunologic indices such as TNF and IFN.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8717394     DOI: 10.1016/0168-1656(95)00104-2

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  18 in total

Review 1.  Filovirus vaccines.

Authors:  Steven B Bradfute; John M Dye; Sina Bavari
Journal:  Hum Vaccin       Date:  2011-06-01

Review 2.  Ebola Vaccine: How Far are we?

Authors:  Rajani Sharma; Ketki Jangid
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 3.  Advances in virus-like particle vaccines for filoviruses.

Authors:  Kelly L Warfield; M Javad Aman
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

Review 4.  A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.

Authors:  Elizabeth R Glaze; Michael J Roy; Lonnie W Dalrymple; Lynda L Lanning
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

Review 5.  Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.

Authors:  John J Suschak; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

Review 6.  Prospects for immunisation against Marburg and Ebola viruses.

Authors:  Thomas W Geisbert; Daniel G Bausch; Heinz Feldmann
Journal:  Rev Med Virol       Date:  2010-11       Impact factor: 6.989

7.  Replication-deficient ebolavirus as a vaccine candidate.

Authors:  Peter Halfmann; Hideki Ebihara; Andrea Marzi; Yasuko Hatta; Shinji Watanabe; M Suresh; Gabriele Neumann; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 8.  Correlates of immunity to filovirus infection.

Authors:  Steven B Bradfute; Sina Bavari
Journal:  Viruses       Date:  2011-06-27       Impact factor: 5.048

Review 9.  Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.

Authors:  Kelly Lyn Warfield; Gene Garrard Olinger
Journal:  J Biomed Biotechnol       Date:  2011-12-28

Review 10.  Forty-five years of Marburg virus research.

Authors:  Kristina Brauburger; Adam J Hume; Elke Mühlberger; Judith Olejnik
Journal:  Viruses       Date:  2012-10-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.